Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 9/2020

24.04.2020 | Original Article – Clinical Oncology

Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis

verfasst von: Jixian Liu, Guangxian Mao, Yingmei Li, Lili Tao, Weifeng Wang, Xuxing Peng, Junbin Wang, Xiaoqiang Li, Xinyu Luan, Ruixing Luo, Tanxiao Huang, Jing Zhang, Mengmeng Xu, Shifu Chen, Da Wu

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Multiple lung lesions found in a single patient at the time of diagnosis often pose a diagnostic dilemma: are these lesions independent primary tumors (IPT) or the result of intrapulmonary metastases (IPM)? While traditional pathological methods sometimes have difficulty distinguishing IPM from IPT, modern molecular profiling based on next-generation sequencing techniques may provide a new strategy.

Methods

Sixteen patients with multiple tumors were enrolled in this study. We performed targeted deep sequencing (~ 2000 × coverage) on a total of 40 tumors and matched blood samples. We compared mutational profiles between tumors within each patient and across patients to evaluate if they were genetically related. Computed tomographic images and histological staining were also used to validate tumor relationships.

Results

A total of 125 mutations were identified in 16 patients. Twelve out of fourteen patients whose histological diagnoses favored IPT did not have any shared mutations in their multiple tumors. The other two showed discrepancies: Pt01 had a shared EGFR exon19 deletion in the two lung tumors found, and Pt16 had one common mutation (BRAFD594G) in two out of five lung tumors. Pt14 with lung metastasis from salivary gland adenoid cystic carcinoma had shared mutations; and Pt15 with suspected intrapulmonary metastasis (IPM) had identical mutations between the two tumors. Visualized data can be readily accessed through the website: mlc.opengene.org.

Conclusion

Analysis of overlapping mutations among different tumors assists physicians in distinguishing IPM from IPT. Our findings demonstrate that DNA sequencing can provide additional evidence in clinical practice when pathology is inadequate to make a conclusive diagnosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Aokage K, Ishii G, Nagai K et al (2007) Intrapulmonary metastasis in resected pathologic stage IIIB non-small cell lung cancer: possible contribution of aerogenous metastasis to the favorable outcome. J Thorac Cardiovasc Surg 134(2):386–391CrossRef Aokage K, Ishii G, Nagai K et al (2007) Intrapulmonary metastasis in resected pathologic stage IIIB non-small cell lung cancer: possible contribution of aerogenous metastasis to the favorable outcome. J Thorac Cardiovasc Surg 134(2):386–391CrossRef
Zurück zum Zitat Chen K, Chen W, Cai J et al (2018a) Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers. J Thorac Cardiovasc Surg 155(1):371–379CrossRef Chen K, Chen W, Cai J et al (2018a) Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers. J Thorac Cardiovasc Surg 155(1):371–379CrossRef
Zurück zum Zitat Chen S, Zhou Y, Chen Y et al (2019) Gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data. BMC Bioinforma 20(Suppl 23):606CrossRef Chen S, Zhou Y, Chen Y et al (2019) Gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data. BMC Bioinforma 20(Suppl 23):606CrossRef
Zurück zum Zitat Chen S, Zhou Y, Chen Y, Gu J (2018c) Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34(17):i884–i890CrossRef Chen S, Zhou Y, Chen Y, Gu J (2018c) Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34(17):i884–i890CrossRef
Zurück zum Zitat Cheng DT, Mitchell TN, Zehir A et al (2015) Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 17(3):251–264CrossRef Cheng DT, Mitchell TN, Zehir A et al (2015) Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 17(3):251–264CrossRef
Zurück zum Zitat Fabian T, Bryant AS, Mouhlas AL, Federico JA, Cerfolio RJ (2011) Survival after resection of synchronous non-small cell lung cancer. J Thorac Cardiovasc Surg 142(3):547–553CrossRef Fabian T, Bryant AS, Mouhlas AL, Federico JA, Cerfolio RJ (2011) Survival after resection of synchronous non-small cell lung cancer. J Thorac Cardiovasc Surg 142(3):547–553CrossRef
Zurück zum Zitat Gaikwad A, Souza CA, Inacio JR et al (2014) Aerogenous metastases: a potential game changer in the diagnosis and management of primary lung adenocarcinoma. Am J Roentgenol 203(6):W570–W582CrossRef Gaikwad A, Souza CA, Inacio JR et al (2014) Aerogenous metastases: a potential game changer in the diagnosis and management of primary lung adenocarcinoma. Am J Roentgenol 203(6):W570–W582CrossRef
Zurück zum Zitat Girard N, Pao W, Deshpande C et al (2009) Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 33(12):1752–1764CrossRef Girard N, Pao W, Deshpande C et al (2009) Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 33(12):1752–1764CrossRef
Zurück zum Zitat Govindan R, Ding L, Griffith M et al (2012) Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150:1121–1134CrossRef Govindan R, Ding L, Griffith M et al (2012) Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150:1121–1134CrossRef
Zurück zum Zitat Koboldt DC, Zhang Q, Larson DE et al (2012) VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22(3):568–576CrossRef Koboldt DC, Zhang Q, Larson DE et al (2012) VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22(3):568–576CrossRef
Zurück zum Zitat Lawrence MS, Stojanov P, Polak P et al (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499:214CrossRef Lawrence MS, Stojanov P, Polak P et al (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499:214CrossRef
Zurück zum Zitat Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows–Wheeler transform. Bioinformatics 26(5):589–595CrossRef Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows–Wheeler transform. Bioinformatics 26(5):589–595CrossRef
Zurück zum Zitat Li H, Handsaker B, Wysoker A et al (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25(16):2078–2079CrossRef Li H, Handsaker B, Wysoker A et al (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25(16):2078–2079CrossRef
Zurück zum Zitat Li R, Li X, Xue R et al (2018) Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs). Thorax 73(3):290–292CrossRef Li R, Li X, Xue R et al (2018) Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs). Thorax 73(3):290–292CrossRef
Zurück zum Zitat Liu Y, Zhang J, Li L et al (2016) Genomic heterogeneity of multiple synchronous lung cancer. Nat Commun. 7:1–8 Liu Y, Zhang J, Li L et al (2016) Genomic heterogeneity of multiple synchronous lung cancer. Nat Commun. 7:1–8
Zurück zum Zitat Macmahon H, Naidich DP, Goo JM et al (2017) Guidelines for management of incidental pulmonary nodules MacMahon et al. Radiol Radiol 284:228–243CrossRef Macmahon H, Naidich DP, Goo JM et al (2017) Guidelines for management of incidental pulmonary nodules MacMahon et al. Radiol Radiol 284:228–243CrossRef
Zurück zum Zitat Martini N, Melamed MR (1975) Multiple primary lung cancers. J Thorac Cardiovasc Surg 70(4):606–612CrossRef Martini N, Melamed MR (1975) Multiple primary lung cancers. J Thorac Cardiovasc Surg 70(4):606–612CrossRef
Zurück zum Zitat Murphy SJ, Aubry MC, Harris FR et al (2014) Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer. J Clin Oncol 32(36):4050–4058CrossRef Murphy SJ, Aubry MC, Harris FR et al (2014) Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer. J Clin Oncol 32(36):4050–4058CrossRef
Zurück zum Zitat Sweeney SM, Cerami E, Baras A et al (2017) AACR project genie: powering precision medicine through an international consortium. Cancer Discov 7(8):818–831CrossRef Sweeney SM, Cerami E, Baras A et al (2017) AACR project genie: powering precision medicine through an international consortium. Cancer Discov 7(8):818–831CrossRef
Zurück zum Zitat Team TNLSTR (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 365(5):395–409CrossRef Team TNLSTR (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 365(5):395–409CrossRef
Zurück zum Zitat Wu C, Zhao C, Yang Y et al (2015) High discrepancy of driver mutations in patients with NSCLC and synchronous multiple lung ground-glass nodules. J Thorac Oncol. 10(5):778–783CrossRef Wu C, Zhao C, Yang Y et al (2015) High discrepancy of driver mutations in patients with NSCLC and synchronous multiple lung ground-glass nodules. J Thorac Oncol. 10(5):778–783CrossRef
Zurück zum Zitat Yatabe Y, Kerr KM, Utomo A et al (2015) EGFR mutation testing practices within the Asia pacific region: results of a multicenter diagnostic survey. J Thorac Oncol 10(3):438–445CrossRef Yatabe Y, Kerr KM, Utomo A et al (2015) EGFR mutation testing practices within the Asia pacific region: results of a multicenter diagnostic survey. J Thorac Oncol 10(3):438–445CrossRef
Zurück zum Zitat Zehir A, Benayed R, Shah RH et al (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23(6):703–713CrossRef Zehir A, Benayed R, Shah RH et al (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23(6):703–713CrossRef
Metadaten
Titel
Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis
verfasst von
Jixian Liu
Guangxian Mao
Yingmei Li
Lili Tao
Weifeng Wang
Xuxing Peng
Junbin Wang
Xiaoqiang Li
Xinyu Luan
Ruixing Luo
Tanxiao Huang
Jing Zhang
Mengmeng Xu
Shifu Chen
Da Wu
Publikationsdatum
24.04.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 9/2020
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-020-03227-5

Weitere Artikel der Ausgabe 9/2020

Journal of Cancer Research and Clinical Oncology 9/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.